- CD38 in the pathobiology of cutaneous T-cell lymphoma and the potential for combination therapeutic intervention: LYMPHOMA
- Short-course subcutaneous alemtuzumab induces clinical responses in relapsed T-cell large granular leukemia
- XPO1 blockade with KPT-330 promotes apoptosis in cutaneous T-cell lymphoma by activating the p53–p21 and p27 pathways
- Optimizing drug combinations for T-PLL: restoring DNA damage and P53-mediated apoptotic responses
- The overlap of skin and blood T-cell clones in early-stage mycosis fungoides
Anjali Mishra, PhD
Assistant Professor, Department of Medical Oncology
Assistant Professor, Department of Medical Oncology